Prepared by Joel L. Nitzkin, MD, on behalf of the tobacco Control Task Force of the American Association of Public Health Physicians (AAPHP), December 22, 2009.
AAPHP urges the Food and Drug Administration (FDA) to classify nicotine vaporizers (Ecigarettes) as a tobacco product
. This classification would be limited to E-cigarettes marketed as an alternative to conventional cigarettes for smokers wishing to avoid the toxic substances (other than nicotine) in cigarette smoke. E-cigarettes marketed for smoking cessation or with other health-related claims could still be regulated as drug-device combinations.
This classification scheme would enable FDA, in collaboration with other federal agencies, voluntaries, and others, to take the action needed to substantially reduce illness and death among current smokers without increasing initiation of nicotine use by children and teens.
The AAPHP Task Force, on the basis of extensive literature review and analysis, has concluded that a national harm reduction initiative, based partly on the potential attractiveness of Ecigarettes to current smokers, could save the lives of 4 million of the 8 million current adult American smokers who will otherwise die of a tobacco-related illness over the next 20 years.
http://www.aaphp.org/special/joelstobac/fdapetition.pdf
This classification scheme would enable FDA, in collaboration with other federal agencies, voluntaries, and others, to take the action needed to substantially reduce illness and death among current smokers without increasing initiation of nicotine use by children and teens.
The AAPHP Task Force, on the basis of extensive literature review and analysis, has concluded that a national harm reduction initiative, based partly on the potential attractiveness of Ecigarettes to current smokers, could save the lives of 4 million of the 8 million current adult American smokers who will otherwise die of a tobacco-related illness over the next 20 years.
http://www.aaphp.org/special/joelstobac/fdapetition.pdf